Prevention of early rebleeding.
A Celal
AC
Iplikçioglu
Sirzat
S
Bek
D000933:Antifibrinolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D023261:Glasgow Outcome Scale; D006801:Humans; D002532:Intracranial Aneurysm / Q000188:drug therapy*; D015337:Multicenter Studies as Topic; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D055502:Secondary Prevention; D013345:Subarachnoid Hemorrhage / Q000188:drug therapy*; D014148:Tranexamic Acid / Q000008:administration & dosage* / Q000009:adverse effects; D020301:Vasospasm, Intracranial / Q000139:chemically induced
D000933:Antifibrinolytic Agents; D014148:Tranexamic Acid